Multiple Sclerosis Clinical Trial
— FARMS-1Official title:
Project FARMS: Fall Risk Reduction in Multiple Sclerosis
Over half of persons with multiple sclerosis (MS) report falling over a 6-month period and a
majority of those who fall require medical attention for injuries. Importantly, balance
dysfunction, muscle weakness, and spasticity are modifiable risk factors for falls among
community-dwelling older adults and likely persons with MS. Indeed, there is evidence that
these physiological risk factors can be minimized with exercise training in persons with MS
and this might translate into a decrease in fall risk as documented in community-dwelling
older adults.
The investigation will examine the effectiveness of a home-based exercise program that is
designed to reduce fall risk by targeting specific fall risk factors including balance
dysfunction and two of its latent causes, muscle weakness and spasticity in persons with
multiple sclerosis. It is predicted that persons who receive home-based exercise program
will have a reduction in fall risk.
| Status | Completed |
| Enrollment | 33 |
| Est. completion date | March 2013 |
| Est. primary completion date | December 2012 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 50 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - having an established definite diagnosis of MS; - being independently ambulatory or ambulatory with an aid; - having the visual ability necessary to read 14 point font; - meeting the age requirement (i.e., 50-75 years of age); - having fallen at least once in the past year and - willingness and ability to attend the training sessions and testing sessions Exclusion Criteria: - non-ambulatory; - risk factors contra-indicative for undertaking strenuous exercise as determined by the physical activity readiness questionnaire. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Illinois UC | Urbana | Illinois |
| Lead Sponsor | Collaborator |
|---|---|
| University of Illinois at Urbana-Champaign |
United States,
Sosnoff JJ, Finlayson M, McAuley E, Morrison S, Motl RW. Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial. Clin Rehabil. 2014 Mar;28(3):254-63. doi: 10.1177/0269215513501092. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Physiological Fall risk | Physiological fall risk will be determined by the physiological profile assessment which assesses physiological function related to fall risk by combining measures of vision, proprioception, lower-limb strength, postural sway, and cognitive function. | 3 months | Yes |
| Secondary | Mobility | Mobility will be quantified with performance on timed 25 foot walk (T25W), timed up and go (TUG), Six spot step test, 6 minute walk and the MS walking scale-12. | 3 months | No |
| Secondary | Balance | Balance will be quantified with the Berg Balance scale; self-report of balance impairment (ABC); and force platform metrics (sway range and velocity). | 3 Months | No |
| Secondary | Spasticity | Spasticity will be assessed with the modified ashworth scale. | 3 Months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|